Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review

INTRODUCTION: Although surgery is the preferred treatment for sarcomatoid hepatocellular carcinoma (SHC), the prognosis remains considerably poor due to early postoperative recurrence and metastasis. Reports on surgery after combined treatment with a tyrosine kinase inhibitor and anti-programmed cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Bin, Huang, Tao, Kuang, Shao-Lei, Xie, Guang-Yuan, Liu, Tian-Qi, Chen, Yuan-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585252/
https://www.ncbi.nlm.nih.gov/pubmed/37869099
http://dx.doi.org/10.3389/fonc.2023.1212013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585252/
https://www.ncbi.nlm.nih.gov/pubmed/37869099
http://dx.doi.org/10.3389/fonc.2023.1212013

Ejemplares similares